Roche presented a real-world data analysis at the 51st Annual Conference of the Research Society for the Study of Diabetes (RSSDI) in Mumbai on the occasion of World Diabetes Day. The presented analysis, conducted for the first time in India, revealed the profound impact of combining regular self-monitoring of blood glucose (SMBG) with the mySugr app on the engagement and glycemic management of people with Type 2 Diabetes (T2DM).
This comprehensive analysis, including almost 40,000 active users with T2DM, focuses on estimated HbA1c (eHbA1c) and Points In Range (PIR), and provides crucial insights into the advantages of utilising technology to enhance diabetes management. The purpose of this analysis was to describe how people with T2DM use the mySugr mobile application and to assess the impact on glycemic management using estimated HbA1c (eHbA1c) and Points In Range (PIR).
The analysis found that integration enhanced patient engagement significantly, and users reported greater frequency of blood glucose monitoring, improved medication adherence, and increased overall awareness of their diabetes care.
Between January 2022 and July 2023, people with T2DM used the mySugr app with 76.1% of them connecting their mySugr app to Bluetooth-enabled glucose meters like Accu-Chek Guide and Accu-Chek Instant, the company said in a press statement.
These users who connected their meters to the mySugr app were more engaged, automatically recording 90.8 blood glucose values on average, compared to 48.75 for non-connected users, it added.
Dr. Caterina Pesenti, Medical and Scientific Affairs Lead, IMEA at Roche Diabetes Care stated, “The results of our real-world data analysis undeniably demonstrates the positive impact of integrating the mySugr app with self-monitoring of blood glucose (SMBG) using blood glucose monitoring systems like Accu-Chek Guide or Accu-Chek Instant in the management of Type 2 Diabetes Mellitus. This technology not only improves engagement but also improves glycemic management, thus enhancing the quality of life for people with Type 2 diabetes.”
Using mHealth systems, such as the mySugr app in conjunction with self-monitoring of blood glucose (SMBG), helps increase patient participation and achieve better glycemic control, it claimed.
